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1. Introduction 
Placenta is a transitory organ which simultaneously separate and connect mother and fetus. It 
has the major importance in the nutrition of fetus, scavenger waste products from fetus, 
secretion of hormones and immunological factors, allowing fetus to grow in a sea of maternal 
immunologic environment and regulating mother metabolism. Also, placenta protects fetus to 
some infectious agents. It has been described that placental barrier is effective to avoid viral, 
bacterial and protozoan fetal infections, such as Cytomegalovirus, Lysteria monocytogenes 
and Trypanosoma cruzi (Dolcini et al., 2008; Leopardi et al., 1994; Robbins et al., 2010).  
Placenta has evolved allowing an independent life to mother. Human placenta is discoidal, 
villous and hemochorial in structure (Benirschke et a., 2006) meaning it has a particular 
structure which is not shared with other commonly species employed in biomedical research 
such as mice. The monkey great apes have similar placenta to human but it is expensive and 
also needs a special environment and protection of rare species. Guinea pig has a hemochorial 
placenta similar to human and it would be necessary to study deeper this specie in relation to 
transmission of infectious agent from mother to fetus at least in Chagas transmission.  
To study human placental invasion by infectious agents, such as Trypanosoma cruzi, 
researchers have three possible models, the culture of either isolated trophoblast or 
chorionic villi explants in interaction with the parasite, or perfusion of placental cotyledons 
in an extracorporeal system, or to analyze the organ from chagasic women obtained at the 
end of pregnancy. The aim of this chapter is to study mechanisms and processes of the 
interaction between placental barrier and the causal agent of Chagas´disease, the 
Trypanosoma cruzi, mainly in vitro systems. Most of the studies with human placenta were 
done in in vitro systems approximately the last 15 years. 
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2. Chagas´disease: some aspects 
Chagas´disease was first described by Carlos Chagas a little more than 100 years ago. He 
described the causal agent, the vectorial transmission and reservoirs and the clinical 
manifestations in humans, that is the complete cycle of the disease. Also, Chagas suggested 
the congenital transmission. Carlos Chagas was nominated twice to the Nobel Prize, but 
never (unfairly) obtained it (Clayton, 2010).  
Chagas disease is an enzootic condition in Latin America, caused by the protozoan 
Trypanosoma cruzi, an obligated intracellular parasite which is transmitted to human by 
different ways. The most common and important of those ways is by the feces of an infected 
triatomine which defecate while feeding. Congenital transmission is another important 
route by which the parasite infects the fetus or the new born, implying in utero or perinatal 
transmission. This review aimed on transplacental transmission of T. cruzi. 
The disease has an acute stage mainly seen in children with no symptoms, or mild 
symptoms or evident ones, such as fever, swelling of lymph nodes, conjunctivitis and skin 
lesions (Kierszenbaum 2007, Teixeira et al. 2006). It has been also described, myocarditis, 
encephalitis and meningitis. Death is a rare condition in this period. All symptoms and 
signals cede spontaneously and patients pass to the indeterminate period of the disease. 
Approximately 12 million of individuals, who are coursing this stage, are positive to specific 
serological tests and neither have symptoms and signs of the disease nor ECG and X ray 
abnormalities, but they are reservoirs for T. cruzi. Approximately one third of all of these 
individuals develop chronic Chagas disease, 20 to 30 years later to acquire it. Chronic 
Chagas disease is associated to cardiomyopathy or digestive disorders. Dead is associated 
with this stage of the disease. 
3. Congenital Chagas transmission (CCT) 
3.1 Definition 
The transmission of live T. cruzi from a chagasic pregnant woman to the fetus implies that 
the new born has the parasite in his/her tissues at the moment of delivery. To consider a 
congenital case, it should fulfill the following conditions: Mother should be positive for T. 
cruzi and also new born should have T. cruzi in their tissues at delivery. Congenital Chagas 
should be diagnosed detecting parasites in infants at delivery or later or detecting own 
antibodies against parasite antigens discarding blood transfusion or vectorial transmission.  
The congenital transmission has been described in pregnant women coursing the acute and 
the indeterminate stages of the disease, even though the incidence of positive transmission 
were higher when mother was in the acute period with high parasitemias (see 5. Survival of 
T. cruzi in the placental environment) (Schijman 2007). Thus, the amount of parasites could 
be an important risk factor for CCT. 
Positive pregnant women may transmit the parasite to one or all siblings, or to jump a 
gestation. However, family clustering has been described, and siblings of a congenital case 
are at high risk that merits testing for Chagas in them (Sanchez-Negrete et al. 2005). 
Frequently, positive children born to chagasic mothers are asymptomatics (Moya et al. 
1979). However, approximately half of the infected new borns depict clinical signs of 
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congenital Chagas disease (Sanchez-Negrete et al. 2005, Torrico et al. 2004). Clinical 
manifestation might appear at delivery, or days or weeks later (Freilij et al. 1994). There is an 
association between premature births and low birth weight with CCT (Azogue 1985, 
Bittencourt 1992, Sanchez-Negrete et al. 2005) and they should be considered as risk factors. 
The condition of chagasic in the mother does not have any consequence on the uninfected 
infant (Shijman 2007). It is controversial if sex participates as risk factor, even though it 
seems there are more males than females congenitally infected with T. cruzi (Bittencourt 
1992, Carlier and Truyens 2010, Torrico et al. 2004). 
3.2 Epidemiological importance of congenital infection by T. cruzi 
The prevalence of Chagas´ disease in pregnant women in South America ranges between 4% 
to 64,4% with 0.1% to 7% of these transmitting the infection to their newborns (Romero 2011, 
WHO 2007). There were 1136 congenital T. cruzi reported cases from 1994 to 2001. 
According to Gurtler et al, (2003) there were more cases than the reported ones; and the 
estimated for these authors was of 6.3 expected cases per each reported case. So, the real 
situation in Argentina, at least in those 8 years was of 7157 new cases in Argentina. As it was 
reported that congenital transmissions was cluster in families, so brothers of congenital 
children are in risk, drawing a very serious picture for Chagas transmission in endemic 
countries due to congenital T. cruzi transmission.  
Congenital transmission has already surpassed the number of vector-mediated acute cases 
by a factor of 10 in Argentina (Gurtler et al 2003). This form of transmission constitutes an 
increasing public health problem and is responsible for the urbanization and spreading of 
the disease to non endemic areas, such as cities of Latin America, United States of America 
and Europe (Schijman, 2007; Clik Lambert, 2008). The permanence of high prevalence of 
chagasic pregnant women in some cities of Latin America is worsening the situation.  
3.3 Possible routes by which T. cruzi reaches the fetus 
Congenital transmission of T. cruzi has been well documented (Freilij et al., 1995, Schijman 
2007). Although this form of transmission was first suggested one hundred years ago by 
Carlos Chagas, the precise route by which the parasite reaches the fetus has not yet been 
elucidated, if there was only one. 
The chorionic villous offers the major surface for interaction between mother and fetus, 
therefore is one of the possible routes that Trypanosoma cruzi employs to infect the placenta 
leading to the congenital Chagas´ disease. It was described the villous trophoblast as being 
the first barrier that T. cruzi must cross in order to reach the offspring (Bittencourt, 1992, 
Schijman, 2007). But, Fernandez-Aguilar (2005) and Moya et al. (1979), studying placentas 
from chagasic mothers, found parasites at the chorionic plate but do not describe parasites 
at the chorionic villi. These authors therefore suggested that the route by which T. cruzi 
accesses the fetus is by hematogenous route through the marginal sinus, spreading into the 
chorionic plate rather than by the trophoblast.  
It was also described that the genital canal at birth could be another route of connatal 
transmission (Schijman 2007). A possible fourth route for T. cruzi congenital transmission 
could be through transfusion of blood from mother to fetus in the uterus (Bianchi and 
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Romero, 2003, Vernochet et al., 2007), mechanism that has not been either studied or 
described yet to the best of our knowledge. 
4. Influence of strains of T. cruzi in the congenital transmission 
Strains of T. cruzi have been involved in different clinical forms of Chagas’ disease (Dutra et 
al. 2005, Zingales et al. 1999), thus implicating a different genetic population in tissue 
tropism, replication and virulence, and in consequences in disease outcome (Dutra et al., 
2005; Macedo et al., 2004; Mejía and Triana, 2005). Maternal conditions, strains of T. cruzi 
and immunological competence of the placenta, might all participate in the congenital 
Chagas’ disease transmission. Whether strains of T. cruzi contribute to congenital infection 
is a matter of controversy. Andrade (1982) found that three different strains of T. cruzi had 
differential tropism to placenta in mice. Epidemiological studies showed geographical 
differences in the incidence and clinical forms of congenital Chagas’ disease (Bittencourt, 
1992). These data may indicate that different T. cruzi strains and/or host individuality 
participate, as suggested by the occurrence of family clustering of congenital Chagas disease 
(Sanchez-Negrete et al, 2005, Schijman 2007). Virreira et al (2006) and Burgos et al., (2007) 
concluded that congenital transmission of T. cruzi is not associated with genetic 
polymorphism of T. cruzi. Recently, Burgos et al. (2007) described that TcIId is the most 
prevalent lineage found in pregnant women both in those who transmit and also in those 
who did not transmit congenitally to their babies and Virreira et al. (2006) found TcIIb, TcIId 
and TcIIe in blood in the umbilical cord, indicating there is not a specific strain of T. cruzi 
implicated in congenital transmission. However, Solana et al. (2002) described biological 
differences among subpopulations of T. cruzi in experimental vertical transmission. 
Furthermore, experimentally in in vitro co-cultures of explants of chorionic villi incubated 
with trypomastigotes of two strains of T. cruzi, it was showed that there are biological 
differences between both strains, surviving more one of the strain with respect to the other 
(Triquell et al. 2009). The survival of specific strain in the placental environment could be 
more important than parasitemia itself to amplify possibilities of infection of the placental 
tissue. Differential susceptibility of different strains of the parasite in the intervillous space 
might explain those cases of high parasitemia of the mother but without congenital 
infection. Andrade et al. (1972) in experimental infections found that the level of parasitemia 
was lower in the two strains of T. cruzi associated with human congenital transmission.  
The data presented above depict a picture of differences between biological behavior 
(Andrade et al. 1972, Lujan et al. 2004) and molecular characterization of different populations 
of T. cruzi (Burgos et al., 2007, Virreyra et al. 2006). On one hand different populations of T. 
cruzi have different biological behavior but there is not a specific DTU of T. cruzi associated to 
CCT. These differences merit further investigation in this area, considering individual factors 
specific to each chagasic pregnant woman (Torrico et al., 2004). 
5. Survival of T. cruzi in the placental environment 
It was demonstrated that trophoblasts and/or other chorionic villi cells produce various 
immunological agents such as hormones, cytokines, nitric oxide and nitrogen and oxygen 
derivatives products (Benirschke et al. 2006, Haugel-de-Mouzon and Guerre-Millo 2006). 
Some of these are also released to the intervillous space. This aspect concomitantly with 
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maternal low blood flow in the intervillous space where T. cruzi might be present in 
chagasic pregnant women, open the possibility that the parasite could be damaged and 
consequently the parasitemia could be reduced or cleaned out of the intervillous space. The 
low flow of the mother blood in the intervillous space might allow the parasiticidal agents to 
destroy the parasite cell limiting the placental invasion by T. cruzi.  
The presence and quantity of parasite cells in the intervillous space seems to be an 
important matter in the congenital transmission of T. cruzi. In the acute stage of the disease, 
the pregnant women have intense and persistent parasitemia (Carlier and Truyens 2010, 
Freilij et al. 1995, Schijman 2007). The rate of T. cruzi transmission from mother to fetus is 
increased when pregnant women coursed an acute stage of the infection, as was described 
by Moretti et al. (2005), and reviewed by Freilij et al. (1994), Carlier and Truyens (2010), 
Bittencourt (1976) and Shijman (2007). Also, in experimental infection, high parasitemia 
worsen mating and pregnancy outcome, with high resorptions of fetuses (Mjihdi et al. 2002, 
Mjihdi et al. 2004, Solana et al. 2009). These results are independent of the strains of the mice 
and of the parasite given that Mjihdi et al. (2002) employed BALB/c mice infected with 
Tehuantepec population of T. cruzi, while Solana et al. (2009) employed C3H/HcN mice 
with K98 clone derived from the CA-I strain of T. cruzi, obtaining similar results.  
There were few publications analyzing the survival of T. cruzi in the placental environment. 
This aspect was studied by Triquell et al. (2009) in in vitro experiments employing chorionic 
villi explants. In this work authors employed the whole placental barrier co-cultured with 
two populations of the T. cruzi, one was the laboratory maintained tulahuen strain and the 
other was isolated from a congenitally acquired new born. To study the effect of placental 
environment upon T. cruzi cell, authors employed two different strategies. In one of them, 
parasites were collected at the end of co-cultures placental explants – trypomastigotes and 
their viability were quantified. The population of T. cruzi obtained from a congenital case 
had a significantly higher survival rate than the tulahuen population of T. cruzi when 
parasites were incubated with chorionic villi explants but there was no difference in their 
survival between both populations when parasites were incubated with Vero cells as 
control. In the other strategy, authors collected culture media from placental explants and 
Vero cells (as control) and then treated trypomastigotes for 1h at 37ºC with those media and 
also with fresh medium as control. Again, culture media from placental explants affect both 
strains of T. cruzi, eventhough there were more viable parasites of the congenital strain of T. 
cruzi. These results indicate that the placental environment alters the viability of the parasite 
cell and that there is a different behavior of different populations of T. cruzi in that 
environment. This aspect is evidently related to the permanence of the parasite in the 
intervillous space. 
Another interesting aspect still poorly analyzed is referred to the time that T. cruzi remains 
in the intervillous space. There is a work that indirectly analyzed this aspect employing a 
placental perfusion model (Shippey et al. 2005). After the spiral arteries cross the basal plate, 
the maternal blood is poured into the intervillous space where circulates around the villi 
outside of the endothelium of the maternal vascular system (Brenishke, 2006). Then, blood 
return to the basal plate where veins drain the maternal blood into de general circulation of 
the mother. Differences between arterial-venous pressure is the force by which the maternal 
blood flows within placenta (Bernishke, 2006). According to a radioangiographic study, 
maternal blood fills rapidly the centers of the villous trees and then spreads slowly toward 
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the centrifugal subchorial and peripheral zones. Due the form of the intervillous space as 
narrow clefts (Bernishke 2006), maternal blood circulates slowly within placenta, allowing T. 
cruzi to interact with placental barrier in chagasic pregnant women. So the question is how 
much time the T. cruzi cell is able to stay in the intervillous space interacting with 
trophoblast? Shippey et al. (2005) used placental perfusion model to study transplacental 
passage of the causal agent of Chagas disease. A solution containing a great mass of 
trypomastigotes of T. cruzi (approximately 107 cells) was injected as a bolus through the 
maternal perfusate flow. Authors have not informed the strain of T. cruzi they employed. 
After the bolus infusion of parasites, the fetal and maternal circulations were maintained 
with sterile saline solution till 2 hs. The PCR (polymerase chain reaction) to detect T. cruzi 
DNA in the fetal and maternal effluents indicated presence of the parasite at 30 min, 60 min 
and 90 min only in the maternal one and was negative (there was not parasite DNA) in the 
fetal effluent. These data implicate that T. cruzi remains within placenta after several flows 
of sterile saline perfusion and also that there was not any passage to fetal circulation despite 
the great mass of parasites injected. This result acquires importance due the differential 
survival that different strains of T. cruzi have in the placental environment and the similar 
infectivity that these strains of the parasite have upon the placental tissue (Triquell et al. 
2009). Thus, the biological characteristics of the parasite may play a role in the permanence 
of T. cruzi in the placental environment and it could be more important than the 
reproduction rate within the placental tissue. 
6. Infection and survival of Trypanosoma cruzi in the placental tissue 
6.1 Mechanism of infection 
Trypanosoma cruzi which could be present in the maternal blood in the intervillous space, 
cross the trophoblastic barrier, the first placental line of defense or other placental tissues 
deprived of trophoblastic defenses. The trypomastigotes into the stromal of chorionic villi 
(the second placental line of defense) and/or chorionic plate constituted by connective 
tissue fibers and cells such as fibroblasts, myofibroblasts and macrophages (Hofbauer cells), 
can further multiplicate within such cells if that have not been destroyed by mesenchymal 
phagocytic cells. The parasite formed nest o pseudocysts which once rupture, releases new 
motile parasites. Sequential infection of other cells, finally infecting myocytes and 
endothelial cells of fetal vessels in villous chorion, chorionic plate and gain access to fetal 
circulation and infect the fetus causing the congenital form of the disease (Bittencourt 1976, 
1992; Carlier 2005; Fernandez Aguilar et al 2005). Some authors believe that the 
trypomastigote have to find a lesion in the trophoblast in order to penetrate the placental 
tissue (Bittencourt 1963) because trophoblast may conform a barrier to T. cruzi infection. 
Histopathological analysis of placentas to brazilian infected women showed placental 
inflammation with villitis and areas of trophoblast destruction or necrosis which induced to 
release inflammatory cytokines such as TNF-┙ and production of local inflammatory 
mediators. These factors can induce a rupture of the trophoblastic barrier facilitating fetal 
infection (Redline 2004). 
The invasion mechanism of the protozoan parasite T. cruzi was originally assumed to be 
similar to the many bacterial pathogens which mobilize the actin cytoskeleton of host cells in 
a phagocytosis-like process (Galan and Bliska 1996). Works studying in vivo invasion 
revealed a gradual accumulation of host cell lysosomes at the parasite entry site, and 
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progressive fusion of these lysosomes with the plasma membrane as invasion proceeded 
into several cell types (Andrews 1995, Sibley and Andrews 2000, Tan and Andrews 2002). 
Morphometric and cytochemical analyses have demonstrated increased lysosomes in 
placentas of women with Chagas disease (Fretes and Fabro 1995)..  
The cortical actin cytoskeleton acts as a barrier for lysosome recruitment and fusion. 
However not polymerized actin was detected around T. cruzi containing intracellular 
vacuoles and invasion was significantly enhanced by disruption of host cell microfilaments 
(Tardieux et al 1992). Sartori et al. (2003) have observed in cultures of explants of placental 
villi in vitro that the parasite induced disassembly of the cortical actin cytoskeleton, and 
authors proposed this is a step in the T. cruzi invasion mechanism into placental cells that 
allowing lysosomes to access to the plasma membrane, and to form the parasitophorous 
vacuole. Fusion of lysosomes with the plasma membrane is required for parasite entry into 
several cell types and that the process is triggered by elevations in intracellular free Ca2+ 
concentration (Burleigh and Andrews 1998). T. cruzi might be taking advantage of Ca2+- 
regulated lysosomal exocytosis in the repair of plasma membrane lesions (Redddy et al. 
2001) for cell invasion. 
 The specific signaling pathway and mechanisms for T. cruzi entry into placental cells is still 
not well understood. In order to understand the process, Calderón and Fabro (1983) studied 
the interaction between syncytial plasma membranes from the human placenta and from the 
parasites; they found modifications of membrane lipids and proteins of the villi trophoblast. 
Also modifications in trophoblast enzymatic activity and in chorionic villi have been 
described (Fretes and Fabro, 1990; Fretes and Fabro, 1994; Fretes and Fabro, 1995). Placental 
alkaline phosphatase (PLAP) is a trophoblast plasma membrane protein and has been 
proposed to have a pathogenetic role in the congenital chagas disease. PLAP activity 
decreased in women with Chagas disease and is related to congenital transmission (Sartori 
et al, 1997) and also is modified in placental villi cultured with T. cruzi (Sartori et al 2002, 
Fretes and Fabro 1990). PLAP anchored to the cell membrane lipid layer by a 
glycosylphosphatidylinositol (GPI) molecule participates in the process of T. cruzi invasion 
into placental syncitiothrophoblast cells by hydrolysis of the GPI molecule (Bertello et al 
2000). Activation of tyrosin kinase proteins increase cytosolic calcium and rearrangement 
actin filaments of the host cells (Shijman 2007). Treatment of microvilli with phospholipase 
C before engagement by T. cruzi hinders parasite invasion into placental trophoblast (Sartori 
et al 2002), probably altering the placental alkaline phosphatase. 
6.2 Placental areas of parasite invasion 
The trophoblast according to Rassi (1958) and Carlier (2010) constitutes a potential barrier to 
penetration of T. cruzi (Bittencourt 1976; Carlier and Truyens 2010). The histopatological 
analyses of placentas from congenital cases display intense villitis with parasites in villous 
trophoblast as well as in villous stromal cells (Bittencourt 1976; Bittencourt 1988; Drut and 
Araujo 2000). However in other studies villitis was uncommon and parasites were not o 
hardly identified in trophoblast (Moya et al 1979; Azogue et al 1985; Carlier 2005). Also the 
parasite was described in the trophoblast but the fetus was free of infection (Bittencourt 
1992). Some in vitro studies mention that trophoblastic cells are easily infected by T. cruzi 
(Sartori et al 2002; Shippey et al 2005) but other authors show low multiplication rate of the 
parasite and the incapacity of T. cruzi to produce a sustainable infection in the normal 
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chorionic villous explants in vitro (Luján et al 2004, Triquell et al. 2009). The different results 
might be referred to different number of parasites employed by researchers, as was 
demonstrated by Duaso et al. (2010) and also to different strains of T. cruzi.  
Parasite was found in placental areas deprived from trophoblast at chorionic plate and 
amastigotes were seen within membranes of amniotic epithelium a fact that may suggest the 
presence of trypomastigotes in the amnionic liquid in association with chorionitis (Moya et 
al 1979; Azogue 1985; Carlier 2005; Fernandez Aguilar et al 2005). Biopsies in placentas from 
infected newborns showed high density of parasites at the level of marginal zone (Carlier 
2005) eluding as a consequence, the defenses of the trophoblast (Lujan et al. 2004).  
6.3 Survival of T. cruzi in the placental tissue: mechanisms of resistance 
Considering the lower congenital transmission incidence and also the report of uninfected 
infants with parasitized trophoblast of chorionic villi (Freillij et al 1994; Bittencourt 1992), it 
argues for the efficacy of the placenta to control the T. cruzi infection.  
Previous analysis involves lysosomes in the T. cruzi invasion into host cells, and also in 
Chagas parasite destruction (Carvalho and de Souza 1989; Milder and Kloetzel 1980). Fretes 
and Fabro (1995) described increasing lysosomes and acid phosphatase activity in chagasic 
placentas without congenital transmission, suggesting that lysosomes population are 
involved in the processes of placental infection and human congenital transmission of 
Chagas disease. Modifications of enzymatic activity in the trophoblast and in chorionic villi 
have been described (Fretes and Fabro, 1990a; Fretes and Fabro, 1990b; Fretes and Fabro, 
1994; Fretes and Fabro, 1995). Furthermore, it was demonstrated that normal human 
placental lysosome subfraction and its supernatant subfractions of normal placentas have 
deleterious effects upon the T. cruzi in in vitro placental cell-free system (Frank et al., 2000). 
In this way it was determined an absence of productive infection of T. cruzi into normal 
chorionic villi in an experimental system of chorionic villi explants co-cultured with the 
parasite in contrast to susceptible cells such as VERO cells (Luján et al. 2004). These findings 
may be in accordance with pathological results found in chagasic placentas, where parasites 
are found in placental chorionic villi but newborns are free of parasites without congenital 
transmission (Bittencourt 1992).  
All of these data were obtained employing an in vitro system of chorionic villi explants co-
cultured with infective forms of the T. cruzi, as have been previously successfully employed 
with bacteria, virus and protozoan (Poliotti. et al 2002). The experimental system employed 
is very similar to the real situation in the uterus where placental villi are floating in the 
intervillous space bathed by the mother´s blood which could contain T. cruzi in the 
pregnant chagasic woman.  
Which are the possible mechanisms involved in the control of productive infection of T. 
cruzi in chorionic villi and protective function of the placenta? Placentas express eNOS and 
iNOS (endothelial and inducible nitric oxide synthases respectively) and produce a large 
amount of Nitric Oxide (NO) (Conrad 1995; Myatt et al 1993, Soorana et al 1999) which has 
been implicated as parasiticidal agent to microorganisms, including T. cruzi (Villalta1998, 
Gobert 2000). The causal agent of Chagas disease is affected by NO, according to in vitro 
and in vivo studies in cardiomyocytes (Fichera et al 2004).  
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According to Triquell et al. (2009) eNOS transcription and protein expression was significantly 
higher when parasites were present in in vitro experimental system. Also, the level of NO in 
the placental environment contains deleterious NO levels to T. cruzi (Triquell et al. 2009, 
Villalta et al. 1998), with two strains of T. cruzi behaving differently in this environment. 
Although there are several immunological mechanism to eliminate the intracellular pathogens 
as NO, parasites have elaborated a variety of strategies to escape of the immune response and 
to make possible their survival and replication in the host. Some parasites modulate the 
production of several toxic molecules synthesized by the immnune system. Interestingly, it has 
been described that some parasites were able to escape to deleterious NO due to the arginase 
induction (Stempin and Cerban, 2007). Consequently, only certain strain of the parasite may 
produce a sustainable infection and offer the subsequent possibility of infecting the fetus in 
pregnant women with Chagas disease. So, at this time, by contrast with information collected 
in experimental murine model (Solana et al., 2002) there is no clear evidence of a relationship 
between T. cruzi genotype and congenital infection in humans (Shijman 2007, Burgos 2007).  
The capacity of each placenta to produce deleterious agents in the placental environment, the 
different susceptibility of strains of T. cruzi in this deleterious medium (Triquell et al. 2009), the 
low capacity of the parasite to induce a reproductive infection in chorionic villi (Lujan et al. 
2004), as well as the possibility that different placental cells types have differential 
susceptibility to be infected by T. cruzi (work that is on going in our lab) can modulate the 
success of transplacental transmission for congenital Chagas disease via chorionic villi route. 
7. Association of placental infection by T. cruzi with other pathological 
conditions 
7.1 Chagas placental alterations and associated pathologies 
It is thought that congenital Chagas´ disease is a product of a complex interaction among the 
maternal immunological or nutritional status, obstetrical history, maternal stage of disease, 
placental factors, and the characteristics of the parasite, such as the strain of T. cruzi or the 
parasitic load (Bittencourt 1992; Carlier, 2005; Burgos, et al 2007), but none of these factors 
have been conclusively demonstrated yet (Moretti et al, 2005).  
During pregnancy, there is an increased susceptibility to certain autoimmune diseases and 
intracellular infections (Guilbert, et al 1993; Lin et al, 2005), like Acquired Immune 
Deficiency Syndrome (AIDS) (Derrien et al, 2005), infections associated with AIDS (Margono 
et al, 1994), malaria (Gamain, et al 2006), toxoplasmosis (Biedermann, 1995), etc. The 
restructured placental barrier possibly facilitates the invasion of diverse pathogens. In 
addition to T. cruzi, other congenital diseases caused by parasites have also been described, 
among which Plasmodium falciparum, the agent responsible for causing malaria, 
(Rogerson, et al, 2007; Desai et al, 2007), schistosoma (Friedman et al, 2007), Toxoplasma 
gondii (Biedermann, 1995; Correa et al, 2007) and Trypanosoma brucei (Rocha et al, 2004) 
are of importance (Kemmerling et al, 2010). 
7.2 Chagas, Diabetes and Hiperglycemia 
Diseases caused by protozoa have been reported to be associated with nutritional 
deficiencies, wasting and diabetes. An association between human T. cruzi infection and 
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obesity and diabetes, has been suspected and there has been general belief, that the 
incidence of diabetes may be increased in the chagasic population (Nagajyothi et al, 2009). 
Pancreas is one of the organs affected in Chagas´ disease. Patients with this disease have 
plasma pancreatic glucagon and pancreatic polypeptide levels reduced (Long et al, 1980), 
lower insulin activity (Guariento et al, 1994), and morphometric and morphologic 
alterations of pancreatic ganglia and islets (Saldanha et al, 2001). Hyperglycemia and 
abnormal glucose tolerance tests observed in some patients with chronic Chagas' disease 
suggest the possibility of morphological changes in pancreatic islets and/or denervation 
(dos Santos et al, 1999; Saldanha et al, 2001). The observed morphometric and morphologic 
alterations are consistent with functional changes in the pancreas, including glycemia and 
insulin disturbances (Saldanha et al, 2001). 
Experimental infections in hamsters caused pancreatitis, erratic blood glucose levels and a 
tendency to hypoinsulinemia (Dos Santos et al, 2004). Diabetes in pregnancy is associated 
with serious abnormalities in the hormonal and metabolic milieu, and in the maternal and 
fetal blood supply. These changes are likely to initiate structural and biochemical alterations 
in placental tissue, which may in turn be related to disturbances in placental functions and 
metabolic performances (Vannini, 1994; Garner, 1995; Desoye & Shafrir, 1996). On the other 
hand, different authors have reported that diabetics have an increased susceptibility to a 
variety of infectious agents (Plouffe et al, 1978, Casey J, Sturm 1982). The course of parasitic 
diseases such as malaria (Tulbert & McGhee, 1960), schistosomiasis (Mahmoud, 1979) and 
trypanosomiasis (Tanowitz et al, 1988) has been studied in diabetic animals.  
Hyperglycemia has been previously observed to increase the morbidity and mortality of 
murine T. cruzi infection (Tanowitz et al, 1988). While T. cruzi infection causes 
hypoglycemia which correlates with mortality, hyperglycemia is associated with increased 
parasitemia and mortality (Nagajyothi et al, 2009). It has also been observed that women 
with the chronic cardiac form of Chagas' disease have diabetes mellitus and disturbances in 
the regulation of glycemic level at a higher frequency than normal controls, probably due to 
reduced activity of the parasympathetic system (dos Santos et al, 1999). But, according to the 
analysis of the bibliography, there is not any study analyzing an association between 
pregnant women affected with both Chagas´ disease and diabetes with congenital 
transmission or with the effect on the new born. Furthermore, there is no marker for 
placental or fetus infection in Chagas´ disease (Mezzano et al, 2012).  
T. cruzi crosses the placental barrier and infects the fetus, causing the congenital form of the 
disease (Bittencourt, 1976). In order to understand the mechanism used by the parasite to 
cross this barrier, the interaction between syncytiotrophoblast plasma membranes from the 
human placenta and the parasite was previously studied, with modifications in lipid and 
protein patterns from trophoblast membranes being found (Calderón, Fabro, 1983). 
However, the mechanism by which the parasite infects the placenta as well as the effects 
upon the protein contents of the placental barrier is still not well understood. 
Due the effect of the Chagas parasite on some proteins located at the lipid raft of chorionic 
villi trophoblast (Fretes RE, de Fabro 1990; Priotto et al, 2009); as well as in trophoblast lipids 
(Fabro AE, Calzolari, 1990), it was analyzed the possible modification of the main glucose 
transporter located at the syncytiotrophoblast, the GLUT1 protein, produced by placental T. 
cruzi infection. These experiments showed that GLUT1 protein expression was significantly 
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diminished in normal placental villi cultured under high glucose concentration in vitro 
infected with T. cruzi, compared to controls (Mezzano et al, 2012).  
It was reported that T. cruzi causes disorganization of the basal membrane of the 
trophoblast and the stroma of the chorionic villi, in in vitro experiments (Duaso et al, 2010). 
Similar changes were registered in human placental explants cultured under high glucose 
concentration, so, both conditions hyperglycemia and T. cruzi infection can modify the 
stroma of the human chorionic villi (Mezzano et al, 2012). 
Furthermore, T. cruzi produces plasmatic membrane modifications, by altering their lipid 
(Fabro AE, Calzolari 1990, Calderón RO, Fabro 1983) and protein components, such as 
Placental Alkaline Phosphatase (Sartori et al, 2003; Lin et al, 2004; Lin et al, 2005; Mezzano et 
al, 2005, Fretes RE, Fabro 1990, Sartori et al, 2005), and Glut1 protein (Mezzano et al, 2012). 
On the other hand, we observed in our laboratory, that Gamma glutamyltranspeptidase, 
another enzyme present in the placenta’s brush border, is not affected in cells co-cultured 
with T. cruzi (Priotto et al, 2009), suggesting that the parasite affects molecules inserted in 
lipid microdomains of the membrane, as PLAP (Salamon et al, 2005) and GLUT1 (Sakyo et 
al, 2007). As the hyperglycemia characteristic of diabetes mellitus also affects these 
membrane components, it was suggested that both the parasite and the high glucose 
conditions could have been provoking, by different ways, a lower placenta efficacy as a 
barrier against infections (Mezzano et al, 2012). Reduced GLUT1 expression observed in 
placental cultures with parasites could imply a down-regulated GLUT1 activity in pregnant 
women with Chagas´ disease. If this disease is causing damage to pancreas islets (Long et al, 
1980; Guariento et al, 1994; Saldanha et al, 2001), or happens together with a previous 
diabetic condition, the adverse effects of reduced GLUT1 activity may be exacerbated. As a 
consequence, it is of importance to perform a systematic study analyzing new born from 
pregnant women who have both conditions diabetes and Chagas (Mezzano et al, 2012).  
It has been described that chorionic villi in vitro has low susceptibility to infection by T. 
cruzi in normal D-glucose concentration (Luján et al, 2004, Triquell et al, 2009). Nagajyothi et 
al. (2010) have been studied the effects of hyperglycemia on T. cruzi infection rekindled by 
the increased incidence of obesity and diabetes mellitus, which have the potential to worsen 
the disease, in areas where T. cruzi infection is endemic. In recent years, there have been 
several studies indicating that diabetes and obesity may be more common in the population 
of individuals at risk for T. cruzi infection (dos Santos et al, 1999; Guariento et al, 1993; 
oliveira et al, 1993; Geraix et al, 2007; Nagajyothi et al, 2009; Nagajyothi et al. 2011; Saldanha 
et al, 2001).  
7.3 Chagas and HIV 
The reactivation of T. cruzi infection is observed in individuals who undergo 
immunosuppressive therapy for malignancies and organ transplantation as well as in 
individuals with human immunodeficiency virus (HIV) infection and AIDS (Tanowitz et al, 
2009; Sartori et al, 2007; Vaidian et al, 2004; Barcán et al, 2005). 
HIV and parasitic infections interact and affect each other mutually. Whereas HIV infection 
may alter the natural history of parasitic diseases, impede rapid diagnosis or reduce the 
efficacy of antiparasitic treatment, parasitoses may facilitate the infection with HIV as well 
as the progression from asymptomatic infection to AIDS. There are data on known 
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interactions for malaria, leishmaniasis, Human African Trypanosomiasis, Chagas' disease, 
onchocerciasis, lymphatic filariasis, schistosomiasis and intestinal helminthiases. The 
common immunopathogenetic basis for the deleterious effects of parasitic diseases may 
have on the natural history of HIV infection seems to be a particular type of chronic immune 
activation and a preferential activation of the T helper (Th)2 type of help. Control of 
parasitic diseases should complement the tools currently used in combating the HIV 
pandemic (Harms and Feldmeier, 2002). 
While for Human African Trypanosomiasis, as well as for onchocerciasis and lymphatic 
filariasis there is little evidence for an interaction with HIV as yet, T. cruzi clearly behaves as 
an opportunistic agent in the presence of HIV infection (Harms and Feldmeier, 2002). In 
analogy to the mechanisms in Leishmania/HIV co-infections, the ongoing 
immunosuppression allows T. cruzi to multiply, particularly in the chronic stage of Chagas´ 
disease (Perez-Ramirez et al. 1999). Clinically, it may be difficult to differentiate Chagas' 
disease reactivation as a consequence of HIV infection and chronic chagasic disease. 
However, reactivation of Chagas' disease in HIV-positive individuals is always associated 
with high parasitaemia, while in chronic disease, parasitaemia is very low and can only be 
detected by xenodiagnosis (Perez-Ramirez et al, 1999). Treatment of T. cruzi infection in 
HIV-positive individuals is recommended to be started early in the reactivation process 
when irreversible alterations have not yet occurred (Sartori et al, 1998). 
Almeida and col. (2010) studied the prevalence of Chagas' disease among HIV seropositive 
patients, registering that the prevalence of co-infected subjects was 1.3% (Almeida et al, 
2010). Dolcini and col. (2008) demonstrated that the presence of an intracellular pathogen, 
such as T. cruzi, is able to impair HIV-1 transduction in an in vitro system of human 
placental histocultures. Direct effects of the parasite on cellular structures as well as on 
cellular/viral proteins essential for HIV-1 replication might influence viral transduction in 
this model. Nonetheless, additional mechanisms including modulation of 
cytokines/chemokines at placental level could not be excluded in the inhibition observed. 
Further experiments need to be conducted in order to elucidate the mechanism(s) involved 
in this phenomenon. Therefore, coinfection with T. cruzi may have a deleterious effect on 
HIV-1 transduction and thus could play an important role in viral outcome at the placental 
level (Dolcini et al 2008). 
Maternal viral load and immunological status are the main factors that determine the risk of 
HIV- Mother-to-child transmission (MTCT) (Bongertz 2001; Scarlatti, 2004). Other risk 
factors are coinfections of the mother (WHO/UNAIDS 1999, Hotez etal, 2006), an important 
issue since world regions with the highest prevalence of HIV-1 infection are also affected by 
other infections. Thus, HIV positive pregnant women are usually infected with other 
pathogens, and such placental coinfections may have consequences on mother to child 
transmission of the pathogens. 
Data from HIV-T.cruzi coinfected patients indicated reactivation of parasite infection with 
exacerbation of clinical signs and unusual clinical manifestations (Ferreira MS, Borges 2002; 
Harms G, Feldmeier, 2002; Sartori et al, 2002; Sartori et al, 2007). Even if no evidence exist of 
coinfection in the mothers, MTCT of both pathogens with severe outcome for the children 
(Freilij H, Altcheh , 1995) and congenital transmission of T. cruzi without confirmation of 
HIV-1 MTCT (Nisida et al, 1999) were reported. However, little is known about interaction 
of both pathogens on an in vitro cellular or ex vivo tissue model.  
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As a result of the significant burden of the HIV pandemics in resource-poor regions, a 
number of potential epidemiological, biological, and clinical interactions between HIV and 
other tropical pathogens gained relevance and need to be studied. The interactions between 
HIV and tropical infectious agents are complex. Each pathogen has the potential to alter the 
epidemiology, natural history, and/ or response to therapy of the other pathogens (Karp & 
Auwaerter, 2007); therefore, it is unpredictable to establish the outcome of such coinfections. 
In Latin America, one of the most significant endemic protozoonoses is Chagas' disease, and 
several clinical studies from HIV-T. cruzi coinfected patients have been reported (Ferreira 
MS, Borges 2002; Harms G, Feldmeier, 2002; Sartori et al, 2002; Sartori et al, 2007). MTCT is 
one way of transmission shared by both pathogens. The exact mechanisms involved in 
MTCT of both pathogens are not clear. Hence, the study of their interaction at the placental 
level is critical for designing strategies that abolish MTCT. In in vitro culture system of term 
placental histocultures, as well as in the trophoblast cell line BeWo, it was demonstrated that 
acute coinfection with T. cruzi and HIV-1 pseudotyped virus decreases HIV-1 replication. 
This is the first report about interaction of these pathogens at the placental level (Dolcini et 
al, 2008). 
A great impairment of HIV-1 replication was observed in coinfection with viable T. cruzi 
trypomastigotes purified from mouse blood (BT). Moreover, when other source of viable 
trypomastigotes was used, such as those grown in cell culture (CT), the same effect on HIV-
1 replication was observed. In all cases, hCG secretion was measured in histoculture 
supernatants and no significant differences were observed between control, viral infection, 
or treatment with trypomastigotes. These results indicate that placental tissue remains 
viable and that parasite impairment of HIV-1 replication was not associated with direct cell 
toxicity caused by T. cruzi. Previous data indicate that the parasite induces rearrangement of 
cortical cytoskeleton of syncytiotrophoblast with actin microfilament depletion during 
human placental invasion (Sartori et al, 2003). Considering that after entering the cell, the 
HIV-1 virion interacts initially with actin filaments which assist binding to microtubules and 
transport to the nuclear periphery (Warrilow and Harrich, 2007), modifications in 
trophoblast cytoskeleton might impair viral replication at an early phase in the case of active 
T.cruzi invasion. However, the inhibition of HIV replication seems to be caused not only by 
viable trypomastigotes but also by soluble factors shed by the parasite, either from BT or CT 
(Dolcini et al, 2008). 
Dolcini et al. (2008) evaluated whether the parasite or its soluble products were able to 
modify the placental environment. In fact, many soluble factors, including cytokines and 
hormones, with regulatory activities are essential for establishing and maintaining 
pregnancy (Saito, 2000; Bowen, 2002). HIV-1 and antiretroviral treatment in pregnant 
women have an impact on the pattern of placental soluble factors (Faye et al, 2007; 
Pornprasert 2006). Little is known about the changes in human fetal-maternal interface in T. 
cruzi infection (Dolcini et al, 2008). 
8. Conclusion 
Spreading of Chagas to non-endemic cities of the world due mainly to congenital Chagas 
transmission put this form of the disease in one of the top public health problem, needing 
more attention for researchers, epidemiologists and governmental officials. There are still 
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many questions not answered yet that need more support to elucidate them. Data from 
chorionic villi-resistance to T. cruzi could lead to obtain mechanisms that lead to prevention 
of fetal infection. 
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